“Studying Calcineurin Inhibitors Metabolic Complications in Egyptian Liver Transplant Patients-A Single Center Trial” (2022) Asian Journal of Pharmaceutics (AJP), 16(3). doi:10.22377/ajp.v16i3.4479.